Christal Mickle
Founder en ZEVRA THERAPEUTICS, INC. .
Fortuna: 772 508 $ al 31/03/2024
Perfil
Christal M.
M.
Mickle is the founder and the Chief Development Officer at Zevra Therapeutics, Inc., a company founded in 2006.
Prior to her current position, she worked as a Research Associate at New River Pharmaceuticals, Inc. from 2002 to 2005.
Ms. Mickle holds a graduate degree from the University of Virginia, which was conferred in 2005, and an undergraduate degree from Virginia Polytechnic Institute & State University, which was conferred in 2001.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC.
0.32% | 22/03/2024 | 133 191 ( 0.32% ) | 772 508 $ | 31/03/2024 |
Cargos activos de Christal Mickle
| Empresas | Cargo | Inicio |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Founder | 30/10/2006 |
Antiguos cargos conocidos de Christal Mickle.
| Empresas | Cargo | Fin |
|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01/01/2005 |
Formación de Christal Mickle.
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
- Bolsa de valores
- Insiders
- Christal Mickle
